DEA Schedule I/Schedule II 1992 production quotas
Executive Summary
DEA's list for 1992 contains proposed quotas for 36 Schedule II controlled substances and 10 Schedule I controlled drugs. For the Schedule II drug, hydrocodone, DEA proposed a production level of 3,891,000 grams, 220,000 grams less than the antitussive/analgesic's 1991 quota ("The Pink Sheet" Feb. 4, In Brief). The 1992 quota for another Schedule II drug, fentanyl is 48,500 grams, 2,000 grams more than the drug's 1991 level. The proposed quota provides for 4,937,000 grams of morphine (for sale), 929,000 grams more than the amount in 1991, and allows for 63,726,000 grams of codeine (for sale), 6,819,000 grams more than in 1991. The DEA announced the proposed quotas in the Aug. 8 Federal Register.
You may also be interested in...
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Shire Hopes To Sow Future Deals With $50M Venture Fund
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth